The firm, launched last September, said in an SEC document that it is targeting $5 million in the financing round.
Researchers involved with the WGS500 study reported on findings from more than 150 clinical cases assessed by whole-genome sequencing.
The partners will sequence genes known to affect drug metabolism and response to create electronic medical record alerts and find clinically relevant gene variants.
Quest has been offering the test since April 13 through its Quest Diagnostics Nichols Institute in San Juan Capistrano, California.
The company has established a streamlined workflow that customizes and automates key steps of the sample prep process.
In Nature this week: factors affecting the success of whole-genome sequencing for routine clinical diagnosis, and more.
A large meta-analysis from an international team reports that nature and nurture have about an equal overall influence on human traits.
The Lasker Foundation's Claire Pomeroy laments the state of NIH funding at Forbes.
Social media is changing how scientists discuss research, as tweets from University of Chicago's Yoav Gilad about a Mouse ENCODE paper have shown, Nature reports.